Navigation Links
New Guidelines Issued for Implanted Heart Devices
Date:5/15/2008

Prevention is as important as intervention, specialists say

THURSDAY, May 15 (HealthDay News) -- New guidelines for implanted heart devices such as pacemakers and defibrillators emphasize that they're just one aspect of cardiac care.

"This is a very specific statement of the importance of optimized medical care," Dr. Andrew Epstein, professor of medicine at the University of Alabama at Birmingham's Division of Cardiovascular Disease, said as he introduced the guidelines Thursday at the Heart Rhythm Society annual meeting, in San Francisco.

The guidelines "will be of tremendous importance not only to cardiologists, but also all physicians as well as the community at large," added Dr. Richard Page, head of the division of cardiology at the University of Washington School of Medicine and program chair of the meeting.

An estimated 180,000 pacemakers and 91,000 defibrillators were implanted in Americans in 2005. Pacemakers keep hearts beating regularly; defibrillators deliver an electric shock to restart an arrested heart or help an irregularly beating heart to return to normal.

The new guidelines update those published in 2002 on implanted cardiac devices. "They are as evidence-based as can possibly be," using information gathered in scores of controlled trials, Epstein said.

The committee drawing up the guidelines included members from the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. The guidelines were expected to be published in the journals and posted on the Web sites of all three organizations.

One important aspect of the new guidelines is that it points out the value of implanted devices in preventing serious coronary problems, rather than being used after such problems occur, Epstein said.

Another important change is that "we have expanded the section on heart failure greatly," Epstein said. Heart failure, which is the progressive loss of the ability to pump blood, is a major contributor to cardiac mortality. An implanted device should be used only if symptoms persist when someone with heart failure already is receiving optimum drug therapy, with medications such as ACE inhibitors and beta blockers, the committee wrote.

The new guidelines also note the importance of talking about the risks and benefits of implanted devices with the patient and family. "We've always tried to do that, and it is formally articulated in the guidelines," Epstein said.

The emphasis on considering implanted devices as one part of an overall strategy arises partly from the greatly expanded used of cardiac medications. For example, more than 80 percent of Americans with coronary disease now get beta blockers, he said.

"We emphasize that the global approach to patients saves lives," Epstein said.

More information

Learn more about heart devices from the U.S. Food and Drug Administration.



SOURCES: Andrew Epstein, M.D., professor of medicine, University of Alabama at Birmingham's Division of Cardiovascular Disease; Richard Page, M.D., head of the division of cardiology, University of Washington School of Medicine, Seattle; May 15, 2008, presentation, Heart Rhythm Society annual meeting, San Francisco


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines
2. ASGE issues updated infection control guidelines for gastrointestinal endoscopy
3. ASGE issues updated guidelines on antibiotic prophylaxis for gastrointestinal endoscopy
4. AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence
5. New Guidelines Show Smokers Have More Tools to Quit Than Ever, But Elected Officials Must Do More to Help
6. Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines
7. Boise(R) BEWARE(R) Meets April 1 Federal Medicaid Guidelines Requiring Tamper-Resistant Prescription Paper
8. Dust Mites Trump Asthma Prevention Guidelines
9. Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers
10. Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM
11. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology: